COST-MINIMIZATION ANALYSIS OF ADDING A NEW SINGLE INHALER TRIPLE THERAPY (SITT) FOR THE TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN THE UK

被引：1
|
作者：
Schroeder, M. [1 ]
Shah, D. [2 ]
Risebrough, N. [3 ]
Ndirangu, K. [2 ]
Martin, A. A. [4 ]
Ismaila, A. [5 ]
机构：
[1] GSK, Brentford, England
[2] ICON Plc, New York, NY USA
[3] ICON Plc, ICON Hlth Econ, Toronto, ON, Canada
[4] GSK, Uxbridge, Middx, England
[5] GSK, Res Triangle Pk, NC USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.04.1595
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PR532
引用
收藏
页码：S235 / S235
页数：1
相关论文
共 50 条
  • [41] Analysis of Chronic Obstructive Pulmonary Disease Exacerbations With the Triple Therapy Compared With Dual and Single Bronchodilator Therapy: Which Treatment Is Better for Patients With Severe Disease?
    Sadigov, Alizamin
    Akhundov, Sakhavatdin
    Bagirov, Rovshan
    CHEST, 2014, 145 (03)
  • [42] Treatment of Hypertension in Patients with Chronic Obstructive Pulmonary Disease (COPD)
    Farsang, C.
    Kiss, I.
    Tykarski, A.
    Narkiewicz, K.
    JOURNAL FUR HYPERTONIE, 2013, 17 (04): : 163 - 165
  • [43] Cost analysis of chronic obstructive pulmonary disease (COPD): a systematic review
    Celia Gutiérrez Villegas
    María Paz-Zulueta
    Manuel Herrero-Montes
    Paula Parás-Bravo
    María Madrazo Pérez
    Health Economics Review, 11
  • [44] COMPARISON OF TWO ECONOMIC MODELS IN THE EVALUATION OF THE COST-EFFECTIVENESS OF TRIPLE THERAPY TREATMENT FOR ADVANCED CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
    Baker, T. M.
    Martin, A.
    Abreu, C.
    Schroeder, M.
    Risebrough, N.
    Ismaila, A. S.
    VALUE IN HEALTH, 2019, 22 : S353 - S353
  • [45] Cost analysis of chronic obstructive pulmonary disease (COPD): a systematic review
    Gutierrez Villegas, Celia
    Paz-Zulueta, Maria
    Herrero-Montes, Manuel
    Paras-Bravo, Paula
    Madrazo Perez, Maria
    HEALTH ECONOMICS REVIEW, 2021, 11 (01)
  • [46] BURDEN OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) PATIENTS UNCONTROLLED DESPITE TRIPLE-THERAPY IN FRANCE
    Antoniali, L.
    Roche, N.
    Bourdin, A.
    Watier, L.
    Vataire, A. L.
    Marcade-Fulcrand, V
    Pages, N.
    Schmidt, A.
    Molinari, N.
    VALUE IN HEALTH, 2023, 26 (12) : S522 - S522
  • [47] Real World Treatment Patterns of Inhaled Triple Therapy (TT) Among Patients with Chronic Obstructive Pulmonary Disease (COPD) in United Kingdom (UK) General Practice
    Sansbury, L.
    Bains, C.
    Landis, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [48] Seroprevalence of Bordetella Pertussis in Patients with Chronic Obstructive Pulmonary Disease (COPD) in the UK
    Richardson, H.
    de Lima, D. Alferes
    Cassidy, D.
    Hennayake, C.
    Haynes, S.
    Keir, H. R.
    Dicker, A.
    Chalmers, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [49] Comparative effectiveness and safety of single inhaler triple therapies for chronic obstructive pulmonary disease: new user cohort study
    Feldman, William B.
    Suissa, Samy
    Kesselheim, Aaron S.
    Avorn, Jerry
    Russo, Massimiliano
    Schneeweiss, Sebastian
    Wang, Shirley, V
    BMJ-BRITISH MEDICAL JOURNAL, 2024, 387
  • [50] COST-EFFECTIVENESS ANALYSIS OF A SINGLE-INHALER TRIPLE THERAPY (TRELEGYA') VS DUAL COMBINATION AND MULTIPLE-INHALER TRIPLE THERAPY FOR THE TREATMENT OF PATIENTS WITH COPD MODERATE TO VERY-SEVERE
    Balmaceda, C.
    Abbott, T.
    Espinoza, M. A.
    VALUE IN HEALTH, 2020, 23 : S354 - S354
12345